SightfileU.S. market data from official filings

Companies › WHWK

Whitehawk Therapeutics Inc (WHWK)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001422142 · EDGAR filings · Updated 2026-06-15

Whitehawk Therapeutics Inc (WHWK) has reported institutional ownership of 72.6%, with 62 institutional managers holding positions valued at $119.5M per the latest 13F reporting period.

Institutional ownership
72.6%
Institutional managers
62
Reported 13F value
$119.5M
Insider activity
6 trans.
−$31.5K net selling

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Whitehawk Therapeutics Inc has 62 institutional holders and institutional ownership of 72.6%.

Insider activity

Insiders reported 6 transactions (0 buys, 3 sells) across 3 reporting insiders, with a net reported value of −$31.5K.

Related companies

Anavex Life Sciences (AVXL) · NKARTA INC (NKTX) · CORBUS PHARMACEUTICALS HLDGS (CRBP) · AGILON HEALTH INC (AGL) · THE ONCOLOGY INSTITUTE INC (TOI) · CLEARPOINT NEURO INC (CLPT)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-15.